BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 7350915)

  • 1. Some kinetic properties of human red cell uroporphyrinogen decarboxylase.
    de Verneuil H; Grandchamp B; Nordmann Y
    Biochim Biophys Acta; 1980 Jan; 611(1):174-86. PubMed ID: 7350915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Erythrocyte porphyrinogen carboxy-lyase activity in porphyria cutanea tarda and certain other human porphyrias.
    Ríos de Molina MC; Wainstok de Calmanovici R; Grinstein M; San Martín de Viale LC
    Clin Chim Acta; 1980 Dec; 108(3):447-56. PubMed ID: 7471475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigations of rat liver uroporphyrinogen decarboxylase. Comparisons of porphyrinogens I and III as substrates and the inhibition by porphyrins.
    Smith AG; Francis JE
    Biochem J; 1981 Apr; 195(1):241-50. PubMed ID: 7306050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced substrate affinity for human erythrocyte uroporphyrinogen decarboxylase constitutes the inherent biochemical defect in porphyria cutanea tarda.
    Mukerji SK; Pimstone NR
    Biochem Biophys Res Commun; 1985 Mar; 127(2):517-25. PubMed ID: 3977935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decarboxylation of uroporphyrinogen III by erythrocyte uroporphyrinogen decarboxylase. Evidence for a random decarboxylation mechanism.
    Luo J; Lim CK
    Biochem J; 1990 Jun; 268(2):513-5. PubMed ID: 2363688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Order of uroporphyrinogen III decarboxylation on incubation of porphobilinogen and uroporphyrinogen III with erythrocyte uroporphyrinogen decarboxylase.
    Luo J; Lim CK
    Biochem J; 1993 Jan; 289 ( Pt 2)(Pt 2):529-32. PubMed ID: 8424794
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro studies of the mechanism of inhibition of rat liver uroporphyrinogen decarboxylase activity by ferrous iron under anaerobic conditions.
    Mukerji SK; Pimstone NR
    Arch Biochem Biophys; 1986 Feb; 244(2):619-29. PubMed ID: 3947082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Defective human erythrocyte uroporphyrinogen decarboxylase in familial porphyria cutanea tarda: the metabolic lesion or the result of endogenous porphyrinemia?
    Mukerji SK; Pimstone NR
    Biochem Biophys Res Commun; 1988 Jul; 154(1):39-46. PubMed ID: 3395340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decarboxylation of uroporphyrinogen I and III in 2,3,7,8-tetrachlorodibenzo-p-dioxin induced porphyria in mice.
    Cantoni L; Dal Fiume D; Ruggieri R
    Int J Biochem; 1984; 16(5):561-5. PubMed ID: 6724109
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tetrapyrroles as substrates and inhibitors of porphyrinogen carboxy - lyase from rat liver.
    San Martín de Viale LC; Aragonés A; Tomio JM
    Acta Physiol Lat Am; 1976; 26(5):403-14. PubMed ID: 1052603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of iron in the pathogenesis of porphyria cutanea tarda. II. Inhibition of uroporphyrinogen decarboxylase.
    Kushner JP; Steinmuller DP; Lee GR
    J Clin Invest; 1975 Sep; 56(3):661-7. PubMed ID: 1159079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liver porphyrinogen carboxylase in hexachlorobenzene porphyric rats. Studies with intermediate porphyrinogens of series III and with uroporphyrinogen I.
    Ríos de Molina MC; Wainstok de Calmanovici R; San Martín de Viale LC
    Int J Biochem; 1987; 19(4):365-72. PubMed ID: 3595984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for two uroporphyrinogen decarboxylase isoenzymes in human erythrocytes.
    Mukerji SK; Pimstone NR
    Biochem Biophys Res Commun; 1987 Aug; 146(3):1196-203. PubMed ID: 3619926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Uroporphyrinogen decarboxylase. Purification, properties, and inhibition by polychlorinated biphenyl isomers.
    Kawanishi S; Seki Y; Sano S
    J Biol Chem; 1983 Apr; 258(7):4285-92. PubMed ID: 6403526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Decreased erythrocyte uroporphyrinogen decarboxylase activity in porphyria cutanea tarda].
    Kondo M
    Nihon Hifuka Gakkai Zasshi; 1985 Aug; 95(9):995-6. PubMed ID: 4079084
    [No Abstract]   [Full Text] [Related]  

  • 16. Abnormal kinetic behavior of uroporphyrinogen decarboxylase obtained from rats with hexachlorobenzene-induced porphyria.
    Chaufan G; Corvi MM; San Martín de Viale LC; Cárdenas ML; Ríos de Molina Mdel C
    J Biochem Mol Toxicol; 2005; 19(1):19-24. PubMed ID: 15736160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decarboxylation of porphyrinogens by rat liver uroporphyrinogen decarboxylase.
    Smith AG; Francis JE
    Biochem J; 1979 Nov; 183(2):455-8. PubMed ID: 534506
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A potential biochemical explanation for the genesis of porphyria cutanea tarda. Studies on the inherent biochemical defect in highly purified human erythrocyte uroporphyrinogen decarboxylase and its amplification by iron.
    Mukerji SK; Pimstone NR; Tan KT
    FEBS Lett; 1985 Sep; 189(2):217-20. PubMed ID: 4043380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Purification and characterization of bovine hepatic uroporphyrinogen decarboxylase.
    Straka JG; Kushner JP
    Biochemistry; 1983 Sep; 22(20):4664-72. PubMed ID: 6626522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Measurement of uroporphyrinogen decarboxylase using porphyrinogens prepared by chemical reduction.
    Elder GH; Wyvill PC
    Enzyme; 1982; 28(2-3):186-95. PubMed ID: 7140720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.